What Does a Hematologist Do? Conditions They Treat
A hematologist is a medical doctor who specializes in diagnosing, treating, and managing diseases involving the blood and the tissues responsible for producing blood cells. These specialists work with conditions affecting red blood cells, white blood cells, platelets, bone marrow, and the body’s clotting system. Their patients may have common problems such as anemia or much rarer inherited blood disorders. Hematologists also diagnose and treat blood cancers, including leukemia, lymphoma, and multiple myeloma, depending on their training. The American Society of Hematology defines a hematologist as a physician specializing in the research, diagnosis, and treatment of blood disorders.
Hematology is a broad specialty because blood performs essential functions throughout the entire body. Red blood cells transport oxygen from the lungs to tissues, white blood cells participate in immune defense, and platelets help stop bleeding after blood vessels become damaged. Plasma carries blood cells along with proteins, hormones, nutrients, electrolytes, and other substances through the circulation. A disorder affecting any of these components can therefore produce symptoms in many different organs. This explains why people may be referred to a hematologist for problems ranging from unexplained fatigue and bruising to abnormal blood counts discovered during a routine checkup.
Hematologists do not treat only cancer, which is an important distinction for patients who become concerned after receiving a referral. Many hematologic conditions are noncancerous, including iron-deficiency anemia, sickle cell disease, thalassemia, hemophilia, von Willebrand disease, immune thrombocytopenia, and blood-clotting disorders. The American Society of Hematology increasingly uses the term classical hematology for noncancerous blood disorders because calling them “benign” can understate how serious some of these conditions can become. Seeing a hematologist therefore does not automatically mean a doctor suspects leukemia or another blood cancer.
Some hematologists focus primarily on classical blood disorders, while others receive combined training in hematology and oncology. Hematologist-oncologists commonly care for people with cancers affecting blood-forming tissues or immune cells. Pediatric hematologists specialize in blood diseases affecting babies, children, and teenagers, while other specialists focus more heavily on clotting, stem cell transplantation, or specific inherited diseases. The field is highly collaborative because abnormal blood findings can result from kidney disease, infections, autoimmune disorders, medications, nutritional deficiencies, cancer, and many other conditions. Your hematologist may therefore work closely with primary care doctors, surgeons, pathologists, oncologists, rheumatologists, nephrologists, or other specialists.
A referral to hematology often begins with something relatively simple, such as an abnormal complete blood count. A low hemoglobin level may indicate anemia, while unusually high or low white blood cell or platelet counts can require additional investigation. These abnormalities sometimes have straightforward explanations and do not necessarily represent serious disease. The hematologist’s role is to determine why the result is abnormal and whether treatment or monitoring is necessary. Cleveland Clinic specifically notes that being referred because of abnormal blood results does not by itself mean a person has a severe illness or blood cancer.
What Does a Hematologist Actually Do?
A hematologist begins by trying to determine which component of the blood is abnormal and what is causing the change. This may involve reviewing previous laboratory results, medical conditions, medications, family history, diet, surgeries, pregnancies, infections, and symptoms. A patient with low hemoglobin, for example, may need evaluation for iron deficiency, vitamin deficiency, chronic inflammation, inherited hemoglobin disorders, kidney disease, or hidden blood loss. Someone with abnormal platelets may require an entirely different workup involving clotting, immune conditions, medications, or bone marrow function. Hematology is therefore heavily focused on connecting laboratory findings with the patient’s broader medical history.
Another major responsibility is interpreting patterns in blood counts rather than looking at individual numbers in isolation. A mildly low white blood cell count can mean something very different from low white cells accompanied by severe anemia and low platelets. Hematologists also examine how quickly values are changing because a stable abnormality present for years can require a different approach from a sudden dramatic change. They may compare several complete blood counts, nutritional tests, clotting studies, and microscopic blood-smear findings before deciding what should happen next. This careful interpretation helps prevent both unnecessary testing and delayed diagnosis of important conditions.
Hematologists also manage long-term blood diseases after the diagnosis has been established. Someone with sickle cell disease may need continuing treatment to reduce complications, while a patient with a chronic clotting disorder may need anticoagulant therapy and regular follow-up. Patients with inherited bleeding disorders may require special planning before surgery, dental procedures, or childbirth. People with chronic anemia may need monitoring and treatment directed at the specific cause rather than repeatedly receiving nonspecific iron supplements. Because many hematologic disorders are lifelong, a hematologist can become an important member of the patient’s healthcare team for years.
Treatment planning can range from relatively simple medication adjustments to highly complex therapies. A hematologist might recommend iron replacement, vitamin therapy, medicines that reduce abnormal blood-cell production, anticoagulants, clotting-factor replacement, blood transfusions, immunotherapy, chemotherapy, targeted drugs, or stem cell transplantation depending on the condition. Some therapies are delivered in outpatient clinics, while serious blood disorders may require hospitalization. Treatment is increasingly personalized using molecular and genetic information when appropriate, particularly for blood cancers and certain inherited conditions. The hematologist’s job includes balancing treatment benefits against risks such as bleeding, infection, clots, medication toxicity, and recurrence.
Hematologists also monitor whether treatment is working and whether complications are developing. Blood counts may be repeated frequently during treatment for leukemia, while someone taking an anticoagulant may need monitoring focused on bleeding and recurrent clot risk. Treatment plans can change when laboratory results, symptoms, or medical circumstances change. Hematologists frequently coordinate care with laboratories and hematopathologists because microscopic, genetic, and molecular analysis of blood or bone marrow can guide diagnosis and treatment. This combination of clinical medicine and detailed laboratory science makes hematology one of the specialties most closely connected with diagnostic testing.
Red Blood Cell Conditions Hematologists Treat
Anemia is one of the most common reasons someone may see a hematologist because it occurs when the blood cannot provide an adequate amount of healthy red blood cells or hemoglobin for the body’s needs. People with anemia may experience fatigue, weakness, shortness of breath, dizziness, headaches, paleness, or rapid heartbeat, although mild cases may produce few symptoms. Anemia is not a single disease because numerous conditions can cause it. A hematologist tries to determine whether the problem involves inadequate blood-cell production, blood loss, abnormal destruction of red cells, or another mechanism. Cleveland Clinic lists anemia among the major noncancerous disorders managed by hematologists.
Iron-deficiency anemia is particularly common, but identifying iron deficiency is only the beginning of the evaluation. The hematologist may need to determine why iron stores became low, especially when the deficiency is severe, recurrent, or unexpected. Heavy menstrual bleeding, gastrointestinal blood loss, inadequate dietary intake, pregnancy, and problems absorbing iron can all contribute. Treatment may involve oral iron, intravenous iron, and investigation or treatment of the underlying source of blood loss. Simply taking iron indefinitely without understanding why deficiency developed can allow an important gastrointestinal, gynecologic, or nutritional problem to remain untreated.
Inherited hemoglobin disorders are another major part of hematology. Sickle cell disease affects hemoglobin and causes red blood cells to become abnormally shaped under certain circumstances, leading to anemia and potentially serious complications involving pain, infection, lungs, kidneys, eyes, bones, and other organs. Thalassemias affect the body’s ability to produce normal hemoglobin chains and range from mild carrier states to severe diseases requiring regular transfusions. Hematologists help confirm the diagnosis, evaluate complications, provide preventive treatment, and coordinate specialized therapies. Genetic counseling may also be useful for individuals or couples carrying inherited hemoglobin variants.
Some anemia develops because red blood cells are destroyed faster than the bone marrow can replace them, a process known as hemolysis. Autoimmune hemolytic anemia occurs when the immune system mistakenly attacks red blood cells, while inherited enzyme or membrane disorders can also shorten cell survival. Hematologists may order blood smears, reticulocyte counts, bilirubin measurements, antibody testing, and other studies to determine whether hemolysis is occurring. Treatment depends on the cause and may involve observation, immune-modifying medication, transfusion support, or treatment of an underlying infection or disease. Correctly identifying the mechanism is essential because giving iron will not correct every form of anemia.
Hematologists also evaluate situations in which red blood cells are unusually high rather than low. Erythrocytosis or polycythemia can result from dehydration, smoking, low oxygen levels, certain medications, or bone marrow diseases such as polycythemia vera. Determining whether the increase is reactive or caused by an abnormal blood-cell-producing process can require specialized laboratory and genetic testing. Some patients need periodic blood removal, medication, or treatment of an underlying condition to reduce complications. Both excessively low and excessively high red blood cell levels therefore fall within the broad expertise of hematology.
Bleeding, Platelet and Blood-Clotting Disorders
Hematologists frequently evaluate people who bleed or bruise more easily than expected. Excessive bleeding can result from too few platelets, abnormal platelet function, or deficiencies involving proteins called clotting factors. Symptoms may include frequent nosebleeds, heavy menstrual bleeding, unusually large bruises, bleeding after dental work, prolonged bleeding from small injuries, or bleeding into muscles and joints. A person’s medical and family history can be particularly important because some bleeding disorders are inherited. Tests are then selected according to the pattern rather than relying on one general “bleeding test.”
Von Willebrand disease and hemophilia are two well-known inherited bleeding disorders managed by hematologists. Von Willebrand disease involves problems with von Willebrand factor, a protein involved in platelet adhesion and blood clotting, while hemophilia usually results from deficiencies of specific clotting factors. Severity varies considerably, and people with mild disease may not discover the condition until surgery, childbirth, or dental work produces unexpectedly prolonged bleeding. Hematologists can develop treatment plans that reduce bleeding risk before procedures and help manage bleeding episodes when they occur. The American Society of Hematology includes both inherited and acquired bleeding disorders within its core patient resources.
Platelet disorders can involve either abnormally low or unusually high platelet counts. Thrombocytopenia means the platelet count is lower than expected and can result from immune destruction, medication effects, infection, liver disease, bone marrow disorders, pregnancy-related conditions, or many other causes. Immune thrombocytopenia, often called ITP, is one example in which the immune system contributes to platelet destruction. Thrombocytosis means platelets are elevated and can occur reactively after inflammation or iron deficiency or as part of certain bone marrow diseases. Hematologists distinguish among these causes because treatment can range from observation to medication or urgent intervention.
Hematologists also treat the opposite problem: blood that forms harmful clots too readily. Deep vein thrombosis occurs when a clot develops in a deep vein, commonly in the leg, while pulmonary embolism occurs when clot material reaches the lungs. Some people develop clots after surgery, prolonged immobility, cancer, pregnancy, estrogen exposure, or other recognizable triggers, while others experience apparently unexplained or recurrent events. A hematologist may help determine whether an inherited or acquired clotting tendency requires investigation. NHLBI notes that people with frequent blood clots may be referred to a hematologist for specialized evaluation.
Treatment of clotting disorders frequently involves anticoagulant medication, but the appropriate drug and duration depend on the individual situation. A short period of anticoagulation may be sufficient after a clearly provoked clot, while recurrent or high-risk thrombosis may require longer therapy. Hematologists also evaluate unusual clot locations, recurrent pregnancy-related clotting concerns, and suspected conditions such as antiphospholipid syndrome. Because anticoagulants themselves increase bleeding risk, treatment requires balancing the danger of another clot against the possibility of excessive bleeding. This is one reason complex or recurrent clotting problems often benefit from specialist hematology input.
Blood Cancers and Bone Marrow Disorders
Blood cancers are another major area of hematology and include leukemia, lymphoma, and multiple myeloma. These diseases begin in blood-forming tissues or cells of the immune system rather than forming a typical solid tumor in one organ. The National Cancer Institute defines blood cancer as cancer beginning in blood-forming tissue such as bone marrow or in immune-system cells. Because blood and immune cells circulate or are distributed throughout the body, diagnosis and treatment differ significantly from many solid cancers. Hematologist-oncologists often lead care for these diseases and coordinate laboratory testing, chemotherapy, targeted therapy, immunotherapy, transplantation, and supportive care.
Leukemia develops when abnormal blood-forming cells multiply and interfere with normal blood production. Different leukemias behave very differently, with some progressing rapidly and requiring urgent treatment while others can remain stable for years. Patients may develop anemia, infection, bruising, bleeding, fatigue, fevers, enlarged lymph nodes, or other symptoms, although leukemia can occasionally be discovered through routine blood testing before obvious symptoms develop. Diagnosis may require a complete blood count, peripheral smear, flow cytometry, bone marrow examination, chromosome studies, and molecular testing. The exact combination helps determine the leukemia subtype and which treatments are most likely to work.
Lymphoma involves abnormal lymphocytes, a type of white blood cell important to immune function. Some lymphomas cause enlarged lymph nodes, fever, night sweats, unexplained weight loss, itching, or persistent fatigue, while others are discovered accidentally. Diagnosis usually requires tissue sampling rather than relying only on a blood test because doctors need to identify the exact lymphoma type. Hematologist-oncologists work closely with pathologists and imaging specialists to determine the disease’s characteristics and extent. Treatment varies from observation in selected slow-growing lymphomas to chemotherapy, immunotherapy, targeted medicines, radiation, or cellular therapy depending on the subtype.
Multiple myeloma is a cancer involving plasma cells, which normally produce antibodies. Abnormal plasma cells can accumulate in bone marrow and interfere with healthy blood-cell production while producing abnormal proteins that may affect the kidneys, bones, nerves, or immune system. Symptoms can include anemia, bone pain, fractures, kidney problems, frequent infections, or elevated calcium, although some precursor plasma-cell conditions cause no symptoms. Diagnosis commonly combines blood and urine tests with bone marrow analysis and imaging. The hematologist then determines whether active treatment is necessary and which therapy best matches the person’s disease characteristics and overall health.
Hematologists also treat bone marrow disorders that do not fit neatly into the three major blood-cancer categories. Myelodysplastic syndromes can interfere with normal development of blood cells, while myeloproliferative neoplasms can cause excessive production of one or more blood-cell types. Conditions such as polycythemia vera, essential thrombocythemia, and myelofibrosis may involve mutations including JAK2, CALR, or MPL that help establish the diagnosis and guide management. NCI notes that genetic and cytogenetic testing of blood or bone marrow can identify mutations and chromosome abnormalities in these disorders. Modern hematology therefore depends increasingly on molecular information alongside traditional blood counts.
When Might You Be Referred to a Hematologist?
One of the most common reasons for referral is an abnormal complete blood count that persists or cannot be easily explained. Your primary care clinician may discover low hemoglobin, unusual white blood cell counts, abnormal platelet levels, or changes involving several cell types at once. A single mildly abnormal result may simply be repeated first because temporary changes can occur after infection, dehydration, medication use, or other short-term events. Referral becomes more likely when abnormalities are significant, repeatedly present, worsening, or accompanied by symptoms. Seeing a hematologist does not automatically mean the abnormal test represents cancer, as many blood-count changes have noncancerous explanations.
Unexplained anemia is another frequent referral reason, particularly when standard treatment has not corrected it. A primary care doctor may initially test iron, vitamin B12, folate, kidney function, and other common causes. Hematology evaluation can become useful when the anemia is severe, recurrent, unusual in appearance, associated with several abnormal blood-cell lines, or possibly caused by hemolysis or bone marrow dysfunction. Blood transfusion requirements can also trigger specialist involvement. The hematologist’s goal is not merely to increase hemoglobin but to establish why normal red blood-cell production or survival has been disrupted.
Unusual bleeding or bruising can lead to referral as well. Someone who develops repeated large bruises without meaningful trauma, has unexpectedly heavy bleeding after dental work, experiences recurrent nosebleeds, or has very heavy menstrual bleeding may need testing of platelets and clotting factors. A family history of abnormal bleeding can increase suspicion for an inherited disorder. Referral is particularly valuable before planned surgery when an underlying bleeding condition is suspected. The specialist can identify whether additional testing or preventive treatment is required to reduce procedural risk.
Blood clots can also lead to hematology consultation, especially when they occur repeatedly, at a young age, in unusual blood vessels, or without an obvious trigger. Some patients are referred because they have had both clotting and pregnancy-related complications or because another family member has an inherited thrombophilia. Not every person with a single deep vein thrombosis requires extensive genetic testing, and indiscriminate testing can sometimes create confusion. A hematologist can decide whether testing is likely to change treatment. The consultation can also address how long anticoagulation should continue and how future surgery, travel, pregnancy, or medications may affect clot risk.
Symptoms alone can occasionally lead directly to hematology evaluation when a doctor suspects a blood or bone marrow disorder. Persistent unexplained fatigue, recurrent infections, prolonged fevers, night sweats, enlarged lymph nodes, unusual bruising, significant unexplained weight loss, or bone pain can sometimes occur with hematologic disease. These symptoms are nonspecific and are far more commonly caused by conditions outside hematology, so they should not be interpreted as proof of blood cancer. What matters is the combination of symptoms, examination findings, and laboratory abnormalities. A hematology referral allows a specialist to decide which possibilities genuinely require further investigation.
What Tests Does a Hematologist Order?
The complete blood count, or CBC, is one of the most fundamental tests in hematology because it measures red blood cells, white blood cells, platelets, hemoglobin, hematocrit, and several related indices. Abnormal results can suggest anemia, infection, inflammation, platelet disorders, bone marrow disease, or blood cancer, depending on the overall pattern. A CBC alone usually cannot identify the exact diagnosis, which is why hematologists often combine it with other investigations. NHLBI describes the CBC as one of the most commonly performed blood tests and notes that abnormalities in different cell types can point toward a wide range of conditions.
A peripheral blood smear allows blood cells to be examined visually under a microscope rather than represented only as numbers from an automated analyzer. The shape, size, maturity, and appearance of red cells, white cells, and platelets can provide valuable diagnostic information. Abnormally shaped red cells may suggest inherited blood disorders or nutritional problems, while immature white blood cells may prompt evaluation for bone marrow disease. Hematologists or hematopathologists can use smear findings to decide whether additional specialized testing is necessary. The American Society of Hematology lists the CBC, clotting tests, and microscopic blood-smear examination among basic methods used to investigate blood abnormalities.
Additional blood tests are chosen according to the suspected condition. Anemia evaluation may involve ferritin, iron studies, vitamin B12, folate, reticulocyte counts, bilirubin, and tests of red blood-cell destruction. Bleeding or clotting evaluation may involve prothrombin time, partial thromboplastin time, fibrinogen, platelet-function testing, specific clotting-factor assays, or specialized tests for thrombophilia. Protein studies can help evaluate plasma-cell disorders, while flow cytometry can identify abnormal populations of white blood cells. Genetic and molecular tests may identify inherited conditions or mutations linked with leukemia, myeloproliferative neoplasms, and other marrow disorders.
A bone marrow aspiration and biopsy may be recommended when blood tests cannot fully explain abnormal blood-cell counts or when leukemia, lymphoma, myeloma, myelodysplastic syndromes, or another marrow condition is suspected. The aspiration removes liquid marrow, while the biopsy removes a small core of marrow-containing tissue for examination. NHLBI explains that these tests can determine whether marrow is healthy and producing normal amounts of blood cells and can help evaluate certain cancers. The procedure is commonly performed using the pelvic bone after local anesthetic is given, although exact techniques vary by situation.
Bone marrow samples can undergo far more than simple microscopic examination. Hematopathologists may assess cell appearance, marrow architecture, immunohistochemical staining, flow cytometry, chromosomes, and molecular changes to build a complete diagnostic picture. The American Society of Hematology notes that aspirate and biopsy components provide complementary information and can be used for morphology, immunophenotyping, cytogenetic studies, and molecular analysis. These advanced tests help distinguish diseases that can initially look very similar on a routine CBC. A hematologist then combines laboratory findings with symptoms and medical history to establish the diagnosis and treatment plan.
How Does a Hematologist Treat Blood Disorders?
Treatment depends entirely on the diagnosis because blood disorders range from mild nutritional deficiencies to life-threatening cancers. A patient with iron-deficiency anemia may receive oral or intravenous iron while the source of deficiency is addressed. Someone deficient in vitamin B12 may need oral supplements or injections depending on why the deficiency developed. Autoimmune blood disorders may require corticosteroids or other medicines that modify immune activity. Some patients need only monitoring because treating a stable mild abnormality can create more harm than benefit. Hematology therefore does not have one universal treatment that applies to every abnormal blood count.
Blood transfusions are an important supportive treatment for selected patients with severe anemia, blood loss, bone marrow failure, or complications of cancer therapy. Platelet transfusions may also be necessary when platelet counts become dangerously low or significant bleeding occurs. People with inherited bleeding disorders can require replacement of missing clotting factors or medicines that increase particular clotting proteins. Transfusion and factor-replacement decisions are based on clinical circumstances rather than laboratory numbers alone. Hematologists carefully balance the benefit of restoring blood function against transfusion reactions, iron accumulation, antibody formation, and other potential complications.
Clotting disorders often require anticoagulant medication that reduces the likelihood of new harmful clots. Depending on the condition, treatment may involve heparin, warfarin, or a direct oral anticoagulant, although individual suitability varies. Hematologists consider why the clot occurred, where it occurred, whether it has happened before, and how great the person’s bleeding risk is. Some conditions require months of treatment, while others justify indefinite anticoagulation. Patients may also need specific instructions about surgery, pregnancy, travel, medications, or situations in which anticoagulation must be interrupted.
Blood cancers can require combinations of chemotherapy, targeted therapy, monoclonal antibodies, immunotherapy, or cellular treatments chosen according to the disease subtype. Advances in molecular testing now allow treatment to target specific genetic or cellular abnormalities in many hematologic cancers. Some leukemias, lymphomas, and plasma-cell disorders can also be treated with stem cell transplantation when appropriate. Treatment intensity varies dramatically because a slowly progressing cancer may initially require observation, while acute leukemia can need urgent hospitalization and therapy. The hematologist-oncologist helps patients understand the goals, expected benefits, side effects, and alternatives associated with each option.
Long-term supportive care is equally important because blood disorders can affect infection risk, bleeding, fatigue, nutrition, bone health, and everyday quality of life. Hematologists may recommend vaccinations, infection prevention, fertility discussions, pain management, genetic counseling, or rehabilitation depending on the condition and treatment. Patients undergoing intensive therapy need close monitoring for treatment complications as well as the underlying disease. Chronic disorders may instead require periodic blood testing and medication adjustment over many years. Successful hematology care therefore involves much more than prescribing a drug; it requires ongoing evaluation of the whole person and how the disease affects daily life.
Hematologist vs Oncologist: What Is the Difference?
A hematologist specializes in blood, bone marrow, and blood-forming or related tissues, while an oncologist specializes in diagnosing and treating cancer. The two specialties overlap because many cancers arise from blood-forming cells, including leukemia, lymphoma, and multiple myeloma. A physician trained in both disciplines is commonly called a hematologist-oncologist. Cleveland Clinic emphasizes that hematologists are not automatically oncologists, although combined training is common because of this natural overlap. The type of specialist you see therefore depends on whether your problem is a noncancerous blood disorder, a blood cancer, or another type of cancer.
Someone with iron-deficiency anemia, hemophilia, immune thrombocytopenia, sickle cell disease, or recurrent blood clots may see a hematologist without ever needing an oncologist. A patient with leukemia may instead be treated by a hematologist-oncologist because the illness falls within both blood medicine and cancer medicine. Someone with breast, lung, colon, or prostate cancer is more likely to see a medical oncologist who focuses primarily on solid tumors. However, hematologists can still become involved if cancer or its treatment produces complicated anemia, clotting, bleeding, or bone marrow problems.
A hematopathologist performs another related but different role. Hematopathology is a branch of pathology focused on interpreting blood, bone marrow, lymph node, and related laboratory specimens. These physicians often examine microscopic cell appearance and integrate flow cytometry, immunostaining, chromosome analysis, and molecular test results. The patient may never meet the hematopathologist directly even though their interpretation is critical to the diagnosis. Clinical hematologists and hematopathologists frequently work together, particularly when evaluating leukemia, lymphoma, myelodysplastic syndromes, or unusual bone marrow findings.
Other specialists may also participate because blood abnormalities frequently reflect diseases originating elsewhere in the body. Gastroenterologists may investigate gastrointestinal bleeding that causes iron deficiency, while gynecologists can help manage heavy menstrual bleeding contributing to anemia. Nephrologists manage kidney diseases that alter red blood-cell production, and rheumatologists may treat autoimmune illnesses affecting blood counts. Surgeons and obstetric teams may coordinate with hematologists when a bleeding or clotting disorder increases procedural risk. Hematology therefore often acts as the specialty connecting laboratory blood abnormalities with problems managed across several areas of medicine.
Patients should not become alarmed simply because a clinic is labeled “hematology-oncology.” Many healthcare systems combine these specialties administratively because the doctors share infusion centers, laboratories, and expertise in blood-cell disorders. A person referred there for anemia or abnormal platelets may have no suspicion of cancer whatsoever. The referral usually means that a clinician believes a specialist in blood disorders can provide a more detailed evaluation. Asking what specifically prompted the referral can help clarify expectations before the appointment and reduce unnecessary worry about the word oncology appearing on the clinic sign.
What to Expect at Your First Hematology Appointment
Your first hematology appointment usually begins with a detailed review of why you were referred and what previous tests have shown. The hematologist may ask about fatigue, shortness of breath, infections, bleeding, bruising, clots, fevers, weight changes, medications, surgeries, and other symptoms depending on the referral. Family history can be important because sickle cell disease, thalassemia, hemophilia, and some clotting disorders can run in families. Menstrual and pregnancy history may also be relevant when evaluating anemia or bleeding. Cleveland Clinic notes that hematologists commonly review overall health, symptoms, existing blood results, possible explanations, and what additional testing may be needed.
Bring a current medication and supplement list because many products can influence blood cells or clotting. Aspirin, anticoagulants, certain antibiotics, chemotherapy medicines, immune-modifying drugs, and even some supplements can alter bleeding risk or blood counts. Previous laboratory reports are useful when they are not already available electronically because trends can reveal whether an abnormality is new, stable, or worsening. Records of prior transfusions, blood clots, surgeries, or significant bleeding episodes can also help. The more complete the history, the easier it becomes to select testing that answers a specific clinical question rather than ordering unnecessary investigations.
A physical examination may focus on signs related to the suspected blood condition. The doctor may look for paleness, jaundice, petechiae, bruising, swollen lymph nodes, enlargement of the liver or spleen, swelling in a limb, or other findings. The examination is usually only one part of the evaluation because hematology relies heavily on laboratory data. Additional blood may be drawn the same day, although specialized tests sometimes require scheduling or insurance authorization. A diagnosis is not always possible at the first visit, particularly when several tests must be completed and compared before a conclusion can be reached.
If a bone marrow biopsy is recommended, that does not automatically mean cancer has already been diagnosed. Bone marrow testing can help explain unexplained low or high blood-cell counts and can identify marrow failure, cancers, and several other conditions. The clinician should explain why the procedure is being recommended, what information it can provide, and what discomfort or risks to expect. NCI describes bone marrow aspiration and biopsy as procedures in which liquid marrow and a small piece of bone-containing marrow are collected for laboratory examination. Patients should feel comfortable asking why a particular test is necessary before agreeing to it.
Useful questions include what the abnormal result means, which conditions are being considered, what additional tests are necessary, and whether treatment is needed immediately or only monitoring is required. You can also ask how often blood counts will be repeated and which symptoms should prompt earlier medical attention. If treatment is recommended, ask about its goal, duration, expected benefits, common side effects, and alternatives. Hematology can involve complicated terminology, so requesting simpler explanations or written information is entirely appropriate. A well-informed patient is better able to follow monitoring plans and recognize when changes require medical attention.
Frequently Asked Questions About Hematologists
Does seeing a hematologist mean I have cancer?
No. Hematologists treat many noncancerous conditions, including anemia, sickle cell disease, bleeding disorders, abnormal platelet counts, and blood clots. A referral often begins simply because a blood test needs specialist interpretation.
What blood tests does a hematologist usually order?
Common tests include a complete blood count, blood differential, peripheral blood smear, reticulocyte count, iron or vitamin studies, and clotting tests. More specialized situations may require flow cytometry, genetic testing, or bone marrow aspiration and biopsy.
What conditions does a hematologist treat?
Hematologists treat disorders affecting red cells, white cells, platelets, bone marrow, bleeding, and clotting. Examples include anemia, sickle cell disease, thalassemia, hemophilia, von Willebrand disease, thrombocytopenia, blood clots, leukemia, lymphoma, and multiple myeloma.
What is the difference between a hematologist and a hematologist-oncologist?
A hematologist specializes in blood disorders, including noncancerous diseases, while a hematologist-oncologist has combined training that also covers cancer treatment. Hematologist-oncologists commonly treat blood cancers such as leukemia, lymphoma, and multiple myeloma.
Why would my doctor refer me to a hematologist for anemia?
A referral may be needed when anemia is severe, persistent, recurrent, or not explained by common causes. A hematologist can investigate iron deficiency, vitamin deficiencies, blood loss, inherited disorders, hemolysis, bone marrow problems, and other causes before recommending targeted treatment.
